ArticleAnnals of dermatology2023

Real-World Outcomes of Adalimumab Treatment for Moderate and Severe Psoriasis in Korean Patients (RAPSODI Study).

Dong Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.